skip to content

Early Cancer Institute

 
Read more at: Dr Daniel Muñoz-Espín promoted to Research Professor
Dr Daniel Muñoz Espín promoted to Research Professor

Dr Daniel Muñoz-Espín promoted to Research Professor

28 July 2026

We are delighted to report that Dr Daniel Muñoz-Espín , Group Leader in the Early Cancer Institute and Co-lead of the CRUK Cambridge Centre Thoracic Cancer Programme, has been promoted to Research Professor at the University of Cambridge. Daniel leads a research group that studies the interface between cellular senescence...


Read more at: Bridget Bannerman receives Schlumberger Foundation Future Impact Prize
Schlumberger Faculty for the Future Impact Prize

Bridget Bannerman receives Schlumberger Foundation Future Impact Prize

16 July 2026

We are thrilled to share that Dr Bridget Bannerman, ACED Programme Manager, has been named as one of nine recipients of a Schlumberger Foundation 2026 Faculty for the Future impact prize, a merit-based award that recognises Fellows who are translating their scientific and engineering expertise into initiatives with...


Read more at: Cambridge University and US research team receive Wellcome Discovery Award to study the earliest steps of oesophageal cancer

Cambridge University and US research team receive Wellcome Discovery Award to study the earliest steps of oesophageal cancer

8 July 2026

We are delighted to announce that Early Cancer Institute Researchers Professor Rebecca Fitzgerald and Dr John Lizhe Zhuang have been awarded a seven-year Wellcome Discovery Award, in collaboration with the MRC Biostatistics Unit, the CRUK Cambridge Institute and the Stem Cell Institute, together with USA based colleagues...


Read more at: The Li Ka Shing Early Cancer Institute is up and running!

The Li Ka Shing Early Cancer Institute is up and running!

23 June 2026

We are delighted to have moved back into our beautifully redeveloped building, now known as the Li Ka Shing Early Cancer Institute. During the redevelopment project, we were temporarily based in the Clifford Allbutt Building and, throughout the month of June, our facilities and removals teams have worked tirelessly to...


Read more at: Loke Medical Sciences Fellowship awarded to Dr Chris Jones, Fitzgerald Group
Loke Fellow Dr Chris Jones

Loke Medical Sciences Fellowship awarded to Dr Chris Jones, Fitzgerald Group

16 June 2026

Congratulations to Chris Jones, Assistant Research Professor in the Early Cancer Institute and Clinical Oncologist at Cambridge University Hospitals, on being awarded the Loke Medical Sciences Fellowship. This prestigious early-career research Fellowship, based at King’s College, Cambridge, supports promising young...


Read more at: Harveer Dev awarded promotion to Honorary Consultant in Urology
Harveer Dev in theatre

Harveer Dev awarded promotion to Honorary Consultant in Urology

11 June 2026

We are delighted to report that Early Cancer Institute group leader Harveer Dev has been promoted to the role of Honorary Consultant in Urology at the Cambridge University Hospitals. The post is a joint clinical and academic appointment which will see Harvey continuing his clinical work with prostate cancer patients as...


Read more at: Urine test moves closer to clinic with potential in lung cancer and pulmonary fibrosis
The urine test works by identifying the presence of senescent cells in the lungs – so called “zombie cells”

Urine test moves closer to clinic with potential in lung cancer and pulmonary fibrosis

26 May 2026

A urine test developed by scientists at the University of Cambridge has moved a step closer to clinical use following new findings revealing that it could do more than first thought.


Read more at: ECI steering committee members elected as Fellows of the Academy of Medical Sciences

ECI steering committee members elected as Fellows of the Academy of Medical Sciences

21 May 2026

Congratulations to two members of our steering committee who have been elected as Fellows of the Academy of Medical Sciences. Professor Antonis Antoniou and Professor George Vassiliou are among seven Cambridge academics who have been recognised for their outstanding contributions to advancing medical science, through...


Read more at: Scientists confirm precursor to most common form of oesophageal cancer – offering opportunities to catch the disease early
 3,100 patients were analysed to test whether all oesophageal adenocarcinoma arise from Barrett's oesophagus

Scientists confirm precursor to most common form of oesophageal cancer – offering opportunities to catch the disease early

15 April 2026

Findings published in Nature Medicine show the strongest evidence to date that a condition known as Barrett’s oesophagus is the starting point for all cases of oesophageal adenocarcinoma - the most common type of oesophageal cancer in the developed world - paving the way to improved early detection of the disease.


Read more at: New Cambridge Postdoctoral Fellowship awarded to rising researcher in early cancer

New Cambridge Postdoctoral Fellowship awarded to rising researcher in early cancer

14 April 2026

The new Bjorn Saven Postdoctoral Fellowship in Early Cancer Research, made possible by a generous donation from Bjorn Saven CBE, is a critical initiative to support promising scientists at a pivotal moment in their careers.